Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-033820
Filing Date
2025-04-10
Accepted
2025-04-10 17:16:59
Documents
1
Period of Report
2025-04-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2512047-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2512047-1_4seq1.xml 4 5970
  Complete submission text file 0001104659-25-033820.txt   7557
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Issuer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TREVI THERAPEUTICS, INC. 195 CHURCH STREET, FLOOR 14 NEW HAVEN CT 06510
Business Address
Mazabraud Yann (Reporting) CIK: 0001774702 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38223 | Film No.: 25829247